×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)

PC-9 (人肺癌细胞) (STR鉴定正确)

货号:CL-0668

规格:1×10⁶cells/T25培养瓶

价格: ¥1600

生长培养基:RPMI-164010% FBS1% P/S

数量: - +

  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)
  • PC-9 (人肺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

PC-9 (人肺癌细胞) (STR鉴定正确) ¥1600
PC-9细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1950¥2050

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 PC-9 (人肺癌细胞) (STR鉴定正确)
别称 PC9; PC-9/S1; PC-9S1
种属
生长特性 贴壁细胞,少量悬浮
细胞形态 圆形和纺锤形混合
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:5
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 源自人肺腺癌,该肺组织仍处于分化状态。PC-9(以前称为PC-14)。PC-14 最初于1989 年作为源自人肺腺癌(未分化型)的细胞系存放在RIKEN生物资源中心。该生物资源中心通过短串联重复序列 (STR) DNA 分析发现该细胞系与 PC-9 相同,PC-9 是源自人肺腺癌(分化型)的细胞系。此错误识别发生在细胞系存放在 RIKEN 生物资源中心之前。细胞系的名称更改为 PC-9,以反映这一发现。
年龄(性别) 男性;45岁
组织来源
细胞类型 肿瘤细胞
肿瘤类型 肺癌细胞
生物安全等级 BSL-1
倍增时间 ~48 hours
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 11
    D2S1338 19,20
    D3S1358 16
    D5S818 11
    D7S820 10,11
    D8S1179 11,15
    D13S317 8
    D16S539 9
    D18S51 15
    D19S433 13,15.2
    D21S11 29,30
    FGA 23,25
    PentaD 9,13
    PentaE 11,15
    TH01 7
    TPOX 11
    vWA 17
    D6S1043 13,19
    D12S391 18
    D2S441 11
  • STR鉴定图
参考文献
文献列表
  • circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis(2024/03/08)

    作者:Yan Zhao, Yunlong Jia, Jiali Wang

    期刊:Molecular Cancer

    DOI:10.1186/s12943-024-01957-5

    影响因子 :37.300

    引用产品:CL-0668

  • Original research: Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination(2023/12/01)

    作者:Zhijia Sun, Haixing Mai, Chunyuan Xue

    期刊:Journal for ImmunoTherapy of Cancer

    DOI:10.1136/jitc-2023-007415

    影响因子 :10.900

    引用产品:CL-0668

  • ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1 transcription in lung adenocarcinoma(2024/04/23)

    作者:Kai Wang, Deyu Guo, Tao Yan

    期刊:ONCOGENE

    DOI:10.1038/s41388-024-03041-0

    影响因子 :8.000

    引用产品:CL-0668

  • LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer(2017/01/12)

    作者:Zhihong Zhao, Ju Wang, Shengfa Wang

    期刊:Biomedicine & Pharmacotherapy

    DOI:10.1016/j.biopha.2016.12.122

    影响因子 :7.500

    引用产品:CL-0298 CL-0400 CL-0668

  • Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma(2022/08/11)

    作者:Jichang Liu, Hongchang Shen, Wenchao Gu

    期刊:Frontiers in Immunology

    DOI:10.3389/fimmu.2022.960738

    影响因子 :7.300

    引用产品:CL-0016 CL-0233 CL-0668

  • Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer(2022/11/27)

    作者:Tan, Bo, Zhang, Jingwei, Wang, Wen, Ma, Haibo, Yang, Yuanyuan

    期刊:APOPTOSIS

    DOI:10.1007/s10495-022-01789-y

    影响因子 :7.200

    引用产品:CL-0016 CL-0165 CL-0298 CL-0668 PCK001 PM150110

  • NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence(2024/03/12)

    作者:Shuman Zhen, Yunlong Jia, Yan Zhao

    期刊:Cell Death Discovery

    DOI:10.1038/s41420-024-01892-w

    影响因子 :7.000

    引用产品:CL-0668

  • Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+(2023/03/11)

    作者:Xuexia Yuan, Youfa Duan, Chunxiang Luo

    期刊:BIOCHEMICAL PHARMACOLOGY

    DOI:10.1016/j.bcp.2023.115498

    影响因子 :5.800

    引用产品:CL-0120 CL-0668

  • Identification of key immune cells infiltrated in lung adenocarcinoma microenvironment and their related long noncoding RNA(2024/02/15)

    作者:Kai Wang, Tao Yan, Deyu Guo

    期刊:iScience

    DOI:10.1016/j.isci.2024.109220

    影响因子 :5.800

    引用产品:CL-0668

  • Identifying the critical oncogenic mechanism of LDHA based on a prognostic model of T-cell synthetic drivers(2023/11/23)

    作者:Guanghui Wang, Haotian Zheng, Yunzhi Xiang

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2023.111265

    影响因子 :5.600

    引用产品:CL-0668

  • Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway(2023/02/15)

    作者:Rong Wang, Yihan Hou, Guojun Geng

    期刊:American Journal of Cancer Research

    DOI:PMID:36895968

    影响因子 :5.300

    引用产品:CL-0016 CL-0668

  • MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2(2024/04/23)

    作者:Hui Yu, Xianrong Xu, Lirong Zhu

    期刊:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

    DOI:10.1111/jcmm.18216

    影响因子 :5.300

    引用产品:CL-0668

  • Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner(2021/02/09)

    作者:Peng Xiao, Yukang Liu, Wei Han

    期刊:Molecular Cancer Research

    DOI:10.1158/1541-7786.MCR-20-0541

    影响因子 :5.200

    引用产品:CL-0298 CL-0668

  • Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma(2023/11/10)

    作者:Yong Liu, Zhaofei Pang, Yadong Wang

    期刊:CHEMICO-BIOLOGICAL INTERACTIONS

    DOI:10.1016/j.cbi.2023.110794

    影响因子 :5.100

    引用产品:CL-0668

  • Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer(2022/03/04)

    作者:Xin Wang, Xiaoping Liu, Yanxia Yang

    期刊:Bioengineered

    DOI:10.1080/21655979.2022.2043099

    影响因子 :4.900

    引用产品:CL-0668

  • Comprehensive analysis of cuproptosis and copper homeostasis genotyping and related immune land scape in lung adenocarcinoma(2023/10/02)

    作者:Dayuan Luo, Xiang Wang, Wei Feng

    期刊:Scientific Reports

    DOI:10.1038/s41598-023-43795-3

    影响因子 :4.600

    引用产品:CL-0668

  • Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics(2024/02/06)

    作者:Yunzhi Xiang, Guanghui Wang, Baoliang Liu

    期刊:Journal of Inflammation Research

    DOI:10.2147/JIR.S443240

    影响因子 :4.500

    引用产品:CL-0668

  • Design, synthesis and biological evaluation of rhein–piperazine–furanone hybrids as potential anticancer agents(2024/02/13)

    作者:Yu He, Sisi Zhang, Mengxue Wei

    期刊:RSC Medicinal Chemistry

    DOI:10.1039/D3MD00619K

    影响因子 :4.100

    引用产品:CL-0668

  • MCF2L-AS1/miR-874-3p/STAT3 feedback loop contributes to lung adenocarcinoma cell growth and cisplatin resistance(2023/10/29)

    作者:Min Xu, Jing Zheng, Jun Wang

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2023.e21342

    影响因子 :4.000

    引用产品:CL-0668

  • SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment(2022/10/02)

    作者:Yong Liu, Guoyuan Ma, Jichang Liu

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2022.e10866

    影响因子 :4.000

    引用产品:CL-0016 CL-0094 CL-0298 CL-0668

  • Different lactate metabolism subtypes reveal heterogeneity in clinical outcomes and immunotherapy in lung adenocarcinoma patients(2024/05/06)

    作者:Jing Zhang, Yun Bao, Yang Li

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2024.e30781

    影响因子 :4.000

    引用产品:CL-0668

  • Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma(2023/02/20)

    作者:Jie Zeng, Zhenyu Wu, Meijuan Luo

    期刊:Frontiers in Genetics

    DOI:10.3389/fgene.2023.1024444

    影响因子 :3.700

    引用产品:CL-0016 CL-0668 CL-0716

  • FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC.(2022/09/09)

    作者:Dongmei Hu, Wendi Zhang, ZhuangE Shi

    期刊:Frontiers in Genetics

    DOI:10.3389/fgene.2022.937069

    影响因子 :3.700

    引用产品:CL-0016 CL-0165 CL-0396 CL-0668

  • CircDUS2L (circ_0039908) promotes lung adenocarcinoma progression by upregulating PGAM1 by acting as a miR-590-5p molecular sponge(2023/07/01)

    作者:Qing Tian, Ying Guo, Jinfeng Liu

    期刊:JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

    DOI:10.1002/jbt.23406

    影响因子 :3.600

    引用产品:CL-0005 CL-0016 CL-0668 PB180120 PM150110 PM150210 PM150910

  • Multi-omics analysis of expression profile and prognostic values of connexin family in LUAD(2023/07/17)

    作者:Peng Jiang, Xingfa Huo, Bowen Dong

    期刊:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

    DOI:10.1007/s00432-023-05075-5

    影响因子 :3.600

    引用产品:CL-0016 CL-0094 CL-0298 CL-0668

  • STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis(2023/09/11)

    作者:Wendi Zhang, Dongmei Hu, Zhuang-E Shi

    期刊:International Journal of Medical Sciences

    DOI:10.7150/ijms.84566

    影响因子 :3.600

    引用产品:CL-0016 CL-0165 CL-0668

  • Silencing of circ_0088036 inhibits growth and invasion of lung adenocarcinoma through miR-203/SP1 axis(2024/03/27)

    作者:Xiuhua Liu, Yan Feng, Linna Wang

    期刊:JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

    DOI:10.1002/jbt.23684

    影响因子 :3.600

    引用产品:CL-0668

  • Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis(2021/8/13)

    作者:Baodan Yu, Lixia Zheng, Huiqin Tang

    期刊:Molecular Medicine Reports

    DOI:10.3892/mmr.2021.12349

    影响因子 :3.400

    引用产品:CL-0668

  • KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification(2024/02/07)

    作者:Zhixiang Zhang, Jipeng Guo, Chongwen Gong

    期刊:Cancer Biomarkers

    DOI:10.3233/CBM-230188

    影响因子 :3.100

    引用产品:CL-0668

  • Evaluation of hsa_circ_0000018/let-7f-5p/ FAM96A axis in lung adenocarcinoma progression(2023/11/23)

    作者:Qi Li, Min Zhao, Dandan Hu

    期刊:Cancer Biomarkers

    DOI:10.3233/CBM-230111

    影响因子 :3.100

    引用产品:CL-0668

  • ORC6 acts as an effective prognostic predictor for non‑small cell lung cancer and is closely associated with tumor progression(2024/01/11)

    作者:Letian Chen, Dongdong Zhang, Yujuan Chen

    期刊:Oncology Letters

    DOI:10.3892/ol.2024.14229

    影响因子 :2.900

    引用产品:CL-0668

  • Circ_0043256 upregulates KLF2 expression by absorbing miR-1206 to suppress the tumorigenesis of lung cancer(2023/01/21)

    作者:Ying Zhou, Hongliu Liu, Rui Wang

    期刊:Thoracic Cancer

    DOI:10.1111/1759-7714.14794

    影响因子 :2.900

    引用产品:164210 164210-50 CL-0016 CL-0668 PM150210

  • Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma(2023/02/24)

    作者:Rui Chen, Zhiping Wang, Tianzhu Lu

    期刊:Thoracic Cancer

    DOI:10.1111/1759-7714.14822

    影响因子 :2.900

    引用产品:CL-0016 CL-0161 CL-0165 CL-0166 CL-0298 CL-0668 CM-0161

  • Calponin 3 suppresses proliferation, migration and invasion of non‑small cell lung cancer cells(2021/7/1)

    作者:Chenglin Yang, Shiping Zhu, Weifeng Feng

    期刊:Oncology Letters

    DOI:10.3892/ol.2021.12895

    影响因子 :2.900

    引用产品:CL-0298 CL-0402 CL-0668

  • Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker(2023/01/17)

    作者:Kang Zou, Pengxiang Gao, Xinping Xu

    期刊:Computational and Mathematical Methods in Medicine

    DOI:10.1155/2023/2912968

    影响因子 :2.809

    引用产品:CL-0016 CL-0094 CL-0165 CL-0298 CL-0400 CL-0668

  • Oxymatrine induces apoptosis in non-small cell lung cancer cells by downregulating TRIM46(2024/05/23)

    作者:Yi Zhong, Biaobiao Luo, Min Hong

    期刊:TOXICON

    DOI:10.1016/j.toxicon.2024.107773

    影响因子 :2.800

    引用产品:CL-0668

  • The m6 RNA methylation regulator KIAA1429 is associated with autophagy‐mediated drug resistance in lung cancer(2024/03/15)

    作者:Bo Ma, Lei Xiu, Lili Ding

    期刊:FASEB BioAdvances

    DOI:10.1096/fba.2023-00083

    影响因子 :2.700

    引用产品:CL-0668

  • Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma(2023/10/10)

    作者:Peijun Liu, Long Zhou, Hao Chen

    期刊:PeerJ

    DOI:10.7717/peerj.16242

    影响因子 :2.700

    引用产品:CL-0668

  • Integrin β4 Regulates Cell Migration of Lung Adenocarcinoma Through FAK Signaling(2024/02/08)

    作者:Shusen Zhang, Chengyu Liu, Dengxiang Liu

    期刊:MOLECULAR BIOTECHNOLOGY

    DOI:10.1007/s12033-024-01061-5

    影响因子 :2.600

    引用产品:CL-0668

  • UTMD-mediated delivery of miR-21-5p inhibitor suppresses the development of lung cancer(2021/12/23)

    作者:Xiaoyu Zhou, Haitao Liu, Yingying Pang

    期刊:Tissue & Cell

    DOI:10.1016/j.tice.2021.101719

    影响因子 :2.600

    引用产品:CL-0668

  • Knockdown of circLRWD1 weakens DDP resistance via reduction of SIRT5 expression through releasing miR-507 in non-small cell lung cancer(2022/08/10)

    作者:Zhongbiao Deng, Qimin Tu, Guoliang Hu

    期刊:ANTI-CANCER DRUGS

    DOI:10.1097/CAD.0000000000001364

    影响因子 :2.389

    引用产品:CL-0668

  • NFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma(2024/02/23)

    作者:Liang Wang, Yuanyuan Ma, Shanyuan Zhang

    期刊:ANTI-CANCER DRUGS

    DOI:10.1097/CAD.0000000000001582

    影响因子 :2.300

    引用产品:CL-0668

  • Hsa_circ_0080608 Attenuates Lung Cancer Progression by Functioning as a Competitive Endogenous RNA to Regulate the miR-661/ADRA1A Pathway(2023/10/11)

    作者:Chengbo Ren, Ling Cui, Ruibiao Li

    期刊:HORMONE AND METABOLIC RESEARCH

    DOI:10.1055/a-2179-0283

    影响因子 :2.200

    引用产品:CL-0668

  • High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2(2022/11/29)

    作者:Miao, Jidong, Gao, Yang, Guan, Wenqiang, Yu, Xiaolin, Wang, Yong, Jiang, Ping, Yang, Lili, Xu, Lun, You, Wei

    期刊:Genes & Genomics

    DOI:10.1007/s13258-022-01339-5

    影响因子 :2.100

    引用产品:CL-0668 PB180120

  • Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma(2024/02/29)

    作者:Shuangshuang Zhou, Meiyi Deng, Xuyu Bian

    期刊:CELLULAR AND MOLECULAR BIOLOGY

    DOI:10.14715/cmb/2024.70.2.17

    影响因子 :1.600

    引用产品:CL-0668

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号